Capitolis Liquid Global Markets LLC Vertex Pharmaceuticals Inc Transaction History

Capitolis Liquid Global Markets LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$421.16 - $509.5 $29.9 Million - $36.2 Million	71,000 New	71,000 $31.6 Billion
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $4.6 Million - $5.06 Million	-10,000 Reduced 28.57%	25,000 $11.6 Billion
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $5.89 Million - $7.28 Million	-15,000 Reduced 30.0%	35,000 $16.4 Billion
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $24.5 Million - $26.8 Million	-60,000 Reduced 54.55%	50,000 $20.9 Billion
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $37.7 Million - $45.2 Million	110,000 New	110,000 $44.8 Billion

1,786

231M

1.83M

1.21M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Capitolis Liquid Global Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Liquid Global Markets LLC with notifications on news.